vomiting prevention

Washington, United States | May 1, 2026 Vanda Pharmaceuticals Inc. has announced the U.S. commercial availability of NEREUS™ (tradipitant),...

WASHINGTON, April 8, 2026 Vanda Pharmaceuticals Inc. has announced the initiation of the Thetis clinical trial evaluating NEREUS™ (tradipitant)...